1.5 Percent Ruxolitinib Cream Safe, Effective for Teens With Eczema

FRIDAY, May 31, 2024-- Long-term intermittent use of ruxolitinib cream is well tolerated and provides disease control in adolescent patients with atopic dermatitis (AD), according to a study published online May 2 in the American Journal of...